About 3750 IU Hamsyl Pegaspargase Injection
Experience the opulent efficacy of 3750 IU Hamsyl Pegaspargase Injection, now available at a special price cut for discerning buyers. This decorated antineoplastic agent is expertly crafted for the treatment of acute lymphoblastic leukemia (ALL), boasting a terrific track record in oncology. Purchase with confidence knowing it features a low allergen potential due to pegylation, is preservative and latex free, and requires no reconstitution. The sterile vial delivers a clear, colorless solution, maintaining stability with a shelf life of two years. Exclusively prescription-only, this single-use cytotoxic agent is manufactured and approved in India.
Targeted Oncology Support - Specialized Usage and Application
3750 IU Hamsyl Pegaspargase Injection is specifically indicated as a chemotherapy adjunct for the treatment of acute lymphoblastic leukemia (ALL) in hospital and clinical oncology settings. This intravenous injectable does not require reconstitution, streamlining plant application and administration on clean, sterile surfaces by trained medical professionals. Its PEGylated form ensures prolonged therapeutic action, delivering enzymatic asparaginase activity precisely where it's most needed during intensive cancer care.
Sample Availability, Export Markets, and Certifications
Samples of the 3750 IU Hamsyl Pegaspargase Injection are available upon request for medical institutions or licensed buyers. Purchase orders can be placed following the initial estimate and certification checks. The product is exported globally, with main markets including Asia, the Middle East, Africa, and Europe. It is delivered with all necessary documentation and certifications as per regulatory standards, ensuring reliability and compliance for international clients.
FAQ's of 3750 IU Hamsyl Pegaspargase Injection:
Q: How should the 3750 IU Hamsyl Pegaspargase Injection be administered?
A: The injection is designed for single-use intravenous administration by healthcare professionals in a sterile clinical environment, without the need for reconstitution.
Q: What are the key benefits of using a PEGylated Pegaspargase injection?
A: PEGylation extends the drug's action in the body, lowers allergen potential, and enhances treatment efficacy for patients undergoing chemotherapy for acute lymphoblastic leukemia (ALL).
Q: When is this injection indicated for use in oncology treatments?
A: Hamsyl Pegaspargase Injection is prescribed as part of chemotherapy regimens specifically for patients diagnosed with acute lymphoblastic leukemia (ALL).
Q: Where can this product be purchased and are samples available?
A: The injection can be purchased from authorized suppliers, exporters, and wholesalers in India. Medical institutions may request samples as part of their purchase process.
Q: What precautions should be taken when handling this cytotoxic agent?
A: Proper handling precautions-including use of gloves and safety protocols-should be observed due to its cytotoxic nature, limiting exposure and ensuring safe administration.
Q: What is the shelf life and storage requirement for this injection?
A: The product has a shelf life of 2 years. It should be stored between 2C-8C and must not be frozen to maintain its efficacy.